SCHEMBL3635894

SCHEMBL3635894

CC(C)COC(=O)N1CCC(NS(=O)(=O)c2ccc(Cl)nc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
GPR119 Q8TDV5 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
TSHR P16473 1/20 0.44
GAA P10253 1/20 0.43
THRB P10828 1/20 0.43
F13A1 P00488 1/20 0.43
TGM2 P21980 1/20 0.43
TGM1 P22735 1/20 0.43
RAB9A P51151 1/20 0.43
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
SFRP1 Q8N474 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648715 0.82 ALDH1A1 (0.57) ALDH1A1GPR119HTTRAB9AMAPT
SCHEMBL4315879 0.82 LMNA (0.50) ALDH1A1SMN1; SMN2LMNAHTTKDM4E
SCHEMBL3660279 0.81 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2HTTKDM4EHSD17B10
SCHEMBL3636605 0.78 KDM4E (0.55) ALDH1A1GPR119SMN1; SMN2LMNAHTT
SCHEMBL17807630 0.78 ALDH1A1 (0.85) ALDH1A1SMN1; SMN2HTTKDM4ECYP3A4
SCHEMBL2401347 0.77 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2TSHRF13A1TGM2
SCHEMBL4312740 0.76 CYP3A4 (0.47) ALDH1A1GPR119SMN1; SMN2LMNAHTT
SCHEMBL3839998 0.75 GPR119 (0.51) GPR119RAB9A
SCHEMBL27162489 0.73 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2LMNAHTTKDM4E
SCHEMBL8512198 0.72 ALDH1A1 (0.91) ALDH1A1SMN1; SMN2LMNAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162455-A2 PYRROLOPYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS Glaxo Group Limited (GB) 2010-03-17 EP disclosed
WO-2008145688-A2 PYRROLOPYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS GLAXO GROUP LIMITED (GB) 2008-12-04 WO disclosed